Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1240 - Provider product page

- Provider
- Boster Biological Technology
- Product name
- Anti-Cytokeratin 8/KRT8 Antibody
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for Cytokeratin 8/KRT8 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. Cytokeratin 8/KRT8 information: Molecular Weight: 53704 MW; Subcellular Localization: Cytoplasm . Nucleus, nucleoplasm . Nucleus matrix ; Tissue Specificity: Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma membrane in structures that contain dystrophin and spectrin. Expressed in gingival mucosa and hard palate of the oral cavity.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling.
Clinical biocharacterization of immunophenotype in hepatocellular carcinoma patients.
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.
Luman recruiting factor is involved in stromal cell proliferation during decidualization in mice.
Chen H, Chen X, Pan B, Zheng C, Hong L, Han W
Frontiers in oncology 2022;12:875146
Frontiers in oncology 2022;12:875146
Clinical biocharacterization of immunophenotype in hepatocellular carcinoma patients.
Pan Q, Zhou R, Su M, Wu X, Li R
International journal of clinical and experimental pathology 2017;10(7):7670-7673
International journal of clinical and experimental pathology 2017;10(7):7670-7673
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.
Zhou B, Sun C, Li N, Shan W, Lu H, Guo L, Guo E, Xia M, Weng D, Meng L, Hu J, Ma D, Chen G
International journal of oncology 2016 May;48(5):2087-97
International journal of oncology 2016 May;48(5):2087-97
Luman recruiting factor is involved in stromal cell proliferation during decidualization in mice.
Li X, Lin P, Chen F, Wang N, Zhao F, Wang A, Jin Y
Cell and tissue research 2016 Aug;365(2):437-47
Cell and tissue research 2016 Aug;365(2):437-47
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image

- Experimental details
- Anti-Cytokeratin 8 antibody, PA1240, Western blottingLane 1: HELA Cell LysateLane 2: HT1080 Cell LysateLane 3: COLO320 Cell Lysate
- Additional image
